Variant report
Variant | nsv560040 |
---|---|
Chromosome Location | chr12:104279718-104283721 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:16)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:16 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr12:104281580-104281730 | Hela-S3 | cervix: | n/a | n/a |
2 | CTCF | chr12:104281700-104281850 | AG04450 | lung: | n/a | n/a |
3 | CTCF | chr12:104281580-104281730 | AG10803 | skin: | n/a | n/a |
4 | CTCF | chr12:104281500-104281650 | MCF-7 | breast: | n/a | n/a |
5 | CTCF | chr12:104281560-104281710 | HEK293 | kidney: | n/a | n/a |
6 | CTCF | chr12:104281600-104281750 | SK-N-SH_RA | brain: | n/a | n/a |
7 | POLR2A | chr12:104283359-104283406 | MCF-7 | breast: | n/a | n/a |
8 | POLR2A | chr12:104283352-104283354 | MCF-7 | breast: | n/a | n/a |
9 | POLR2A | chr12:104283356-104283403 | MCF-7 | breast: | n/a | n/a |
10 | POLR2A | chr12:104281527-104281993 | H1-neurons | neurons: | n/a | n/a |
11 | POLR2A | chr12:104283344-104283348 | MCF-7 | breast: | n/a | n/a |
12 | POLR2A | chr12:104281552-104282006 | H1-neurons | neurons: | n/a | n/a |
13 | REST | chr12:104281255-104282297 | H1-neurons | neurons: | n/a | n/a |
14 | SPI1 | chr12:104283489-104283788 | GM12878 | blood: | n/a | n/a |
15 | SPI1 | chr12:104283461-104283768 | GM12891 | blood: | n/a | n/a |
16 | ZEB1 | chr12:104280236-104280616 | GM12878 | blood: | n/a | chr12:104280482-104280489 |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:104272930..104275342-chr12:104282013..104284611,2 | K562 | blood: | |
2 | chr12:104281610..104283570-chr12:104286260..104289028,2 | K562 | blood: | |
3 | chr12:104262529..104265193-chr12:104278298..104280290,2 | K562 | blood: | |
4 | chr12:104277824..104279928-chr12:104282058..104285020,2 | K562 | blood: | |
5 | chr12:104277028..104280742-chr12:104283520..104285730,3 | K562 | blood: | |
6 | chr12:104277028..104280742-chr12:104283520..104285730,3 | K562 | blood: | |
7 | chr12:104277824..104279928-chr12:104282058..104285020,2 | K562 | blood: | |
8 | chr12:104282070..104284528-chr12:104287528..104289517,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000214198 | TF binding region |
ENSG00000214198 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7295782 | chr12:104279718-104279719 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs536638655 | chr12:104279728-104279729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs370371365 | chr12:104279734-104279735 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs557635932 | chr12:104279771-104279772 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs558258934 | chr12:104279772-104279773 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs573954971 | chr12:104279774-104279775 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189504677 | chr12:104279811-104279812 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs181810123 | chr12:104279813-104279814 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs573086832 | chr12:104279816-104279817 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs545524132 | chr12:104279819-104279820 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570089805 | chr12:104279832-104279833 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs150557602 | chr12:104279865-104279866 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs530934801 | chr12:104279881-104279882 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs74952887 | chr12:104279883-104279884 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs558631209 | chr12:104279886-104279887 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs373456002 | chr12:104279887-104279888 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544237738 | chr12:104279892-104279893 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs563587651 | chr12:104279930-104279931 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs185201340 | chr12:104279949-104279950 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs56205268 | chr12:104279994-104279995 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs549279220 | chr12:104279999-104280000 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs73386167 | chr12:104280023-104280024 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs528288464 | chr12:104280027-104280028 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs551503171 | chr12:104280076-104280077 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs571209132 | chr12:104280138-104280139 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs537060055 | chr12:104280144-104280145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs542990105 | chr12:104280181-104280182 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs555127655 | chr12:104280182-104280183 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs7299349 | chr12:104280224-104280225 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs190838055 | chr12:104280225-104280226 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs553241724 | chr12:104280259-104280260 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs140467813 | chr12:104280265-104280266 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs182694594 | chr12:104280287-104280288 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs559018400 | chr12:104280295-104280296 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs546160203 | chr12:104280320-104280321 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs544613488 | chr12:104280345-104280346 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs561297725 | chr12:104280368-104280369 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs73386170 | chr12:104280369-104280370 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs77444663 | chr12:104280377-104280378 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs11111824 | chr12:104280475-104280476 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs186348253 | chr12:104280482-104280483 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs551247484 | chr12:104280501-104280502 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs565007686 | chr12:104280568-104280569 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs371283574 | chr12:104280576-104280577 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs530494825 | chr12:104280590-104280591 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs72359868 | chr12:104280599-104280600 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs144437271 | chr12:104280610-104280611 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs10861134 | chr12:104280622-104280623 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs535841149 | chr12:104280628-104280629 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs374058057 | chr12:104280665-104280666 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22032731 | CNVD |
Cancer | 16751803 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Wilms tumour | 21544195 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 16397240 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Neurocytoma | 17123091 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21364760 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:104275000-104281600 | Weak transcription | Primary T killer naive cells fromperipheralblood | blood |
2 | chr12:104278200-104285800 | Enhancers | Fetal Thymus | thymus |
3 | chr12:104278800-104280200 | Weak transcription | GM12878-XiMat | blood |
4 | chr12:104279200-104284200 | Weak transcription | Thymus | Thymus |
5 | chr12:104280200-104280600 | Enhancers | GM12878-XiMat | blood |
6 | chr12:104280600-104283400 | Weak transcription | GM12878-XiMat | blood |
7 | chr12:104281200-104284200 | Weak transcription | Brain Substantia Nigra | brain |
8 | chr12:104281600-104282200 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
9 | chr12:104282600-104284800 | Weak transcription | Pancreas | Pancrea |
10 | chr12:104282800-104283200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr12:104283200-104283400 | Flanking Active TSS | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr12:104283400-104284000 | Enhancers | GM12878-XiMat | blood |
13 | chr12:104283400-104284400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |